
Diamond Pharmaceuticals (DP) is a pharmaceutical production and distribution outfit aimed at increasing access to pharmaceuticals especially essential drugs to people in Cameroon.
DP strives to achieve its aim by setting up a drug production unit, manufacturing essential drugs and linking up with existing supply chains or setting up other supply routes where there are inadequate supply mechanisms.
We will create legendary patient and healthcare partnership experiences, deliver essential medicines, ensure transparent, objective information and insight, support accessible health choices, provide an environment that is built upon shared values, excellence, energy and the opportunity for staff to realize their full potential,
We will strive to be the best managed company in Central Africa and so contribute to both improved health for underserved communities.
The vision of DP is guided by the belief that all human beings have the right to affordable good quality medicines.
Our vision is to be a leading pharmaceutical company in the Central African region and to become a major player in the African continent by 2015. To become a leading company focused on manufacturing, distributing and commercializing essential drugs to treat diseases and disorders for which there are unmet or under-served medical needs.
We shall seek joint ventures with partners who are major players in their countries or region in order to become the company that consumers trust.
As a pharmaceutical company with region-wide operations focused on manufacturing medicines, DP will create higher quality of life for patients at the lowest cost possible and jobs for highly qualified Africans. We aspire to enrich our people - our driving force, to become highly competent professionals and technology base grounded in our core values of integrity, honesty, trust, respect, support, openness and diversity. Our philosophy is to invest in people who combine qualifications with drive and enthusiasm .This includes our strong commitment to staff training and development.
Provide essential medicines to meet 40% of the pharmaceutical needs to treat opportunistic infections in AIDS patients in Cameroon.
Provide essential medicines to meet 20% of the non-injectable pharmaceutical needs to treat diseases with highest mortality rates in Cameroon
30 to 450ml bottle with a speed of approximately 120 bottles per minute. Other parameters still to be determined
Collaborating Organizations